Marshall Wace, LLP Sema4 Holdings Corp. Transaction History

Marshall Wace, LLP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.22 - $1.04 $141,117 - $667,101	641,444 Added 11.35%	6,291,730 $1.64 Million
Q3 2022 Nov 14, 2022	BUY	$0.25 - $2.4 $183,651 - $1.76 Million	734,605 Added 14.94%	5,650,286 $4.97 Million
Q2 2022 Aug 15, 2022	BUY	$1.22 - $3.05 $110,162 - $275,405	90,297 Added 1.87%	4,915,681 $6.19 Million
Q1 2022 May 16, 2022	BUY	$2.64 - $4.67 $7.54 Million - $13.3 Million	2,855,015 Added 144.9%	4,825,384 $14.8 Million
Q4 2021 Feb 14, 2022	SELL	$4.4 - $8.8 $682,796 - $1.37 Million	-155,181 Reduced 7.3%	1,970,369 $8.79 Million
Q3 2021 Nov 15, 2021	BUY	$7.44 - $13.99 $647,599 - $1.22 Million	87,043 Added 4.27%	2,125,550 $16.1 Million
Q2 2021 Aug 13, 2021	BUY	$10.75 - $16.75 $21.9 Million - $34.1 Million	2,038,507 New	2,038,507 $28.6 Million

166K

Ticker SMFR
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 380,641,984
Market Cap $129M
Description
Sema4 Holdings Corp., doing business as Sema4, operates as a health information company that enhances diagnosis, treatment, and prevention of disease through data. The company provides Centrellis, an AI-driven health intelligence platform that delivers comprehensive insights to biopharma to accelerate the drug discovery, development, and commerc...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.